abstract |
The present invention relates to compounds represented by general formula (I) wherein R 1, R 2, R 3 and n are as defined in the specification. The invention further relates to medicaments containing these compounds and to a process for their preparation. These compounds have an affinity for metabotropic glutamate receptors and are therefore useful in the treatment or prevention of acute and / or chronic neurological disorders. n are as defined in the specification. The invention further relates to medicaments containing these compounds and to a process for their preparation. The compounds possess affinity towards metabotropic glutamate receptors and are therefore useful in the treatment or prevention of acute and / or chronic neurological disorders. |